Marie‐Eve Ebelin

Pimecrolimus Identifies a Common Genomic Anti-inflammatory Profile, is Clinically Highly Effective in Psoriasis and is Well Tolerated

Klemens Rappersberger, Michael Komar, Leo Richter et al. · Journal of Investigative Dermatology · 2002 · 115 citations

Inflammation, Autoimmune Disease, Medicine +8

Occlusive Treatment of Chronic Hand Dermatitis with Pimecrolimus Cream 1% Results in Low Systemic Exposure, Is Well Tolerated, Safe, and Effective

Diamant Thaçi, Katrin Steinmeyer, Marie‐Eve Ebelin et al. · Dermatology · 2003 · 57 citations

Low Systemic Absorption and Good Tolerability of Pimecrolimus, Administered as 1% Cream (Elidel®) in Infants with Atopic Dermatitis – A Multicenter, 3‐Week, Open‐Label Study

Doris Staab, David M. Pariser, Alice B. Gottlieb et al. · Pediatric Dermatology · 2005 · 46 citations

Use of Human Skin Equivalent Apligraf for in Vitro Assessment of Cumulative Skin Irritation Potential of Topical Products

J. Medina, Anne de Brugerolle de Fraissinette, Salah‐Dine Chibout et al. · Toxicology and Applied Pharmacology · 2000 · 25 citations

Medicine, Topical Products, Topical Drug +9

Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel^®) for up to 1 year

E.J.M. van Leent, Henry J.C. de Vries, Marie‐Eve Ebelin et al. · Journal of Dermatological Treatment · 2007 · 20 citations